Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RegenMed Biotech is an Indian biotechnology company specializing in regenerative medicine and advanced cell-based therapies. The company focuses on the development and commercialization of stem cell products, including mesenchymal stem cells (MSCs) and platelet-rich plasma (PRP), for a wide range of clinical applications. Their primary therapeutic focus areas include orthopedics, wound healing, and aesthetics, with a flagship product line marketed under the "Regen" brand. RegenMed Biotech operates a state-of-the-art GMP-certified manufacturing facility and provides specialized cell processing services to hospitals and clinics across India.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ReGenMed Biotech.